Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

December 3, 2013

Marlborough Firm Raises $63M Through IPO

Oxford Immunotec Global PLC, a medical diagnostic company with U.S. headquarters in Marlborough, has raised $62.8 million through an initial public offering of stock that closed Monday.

The company, based in Oxford, England, sold 6.16 million shared of its stock at $12 per share, with the underwriters exercising in full their option to buy an additional 804,000 shares. The company’s stock price ended Monday at $15.75.

Oxford’s stock is trading on the NASDAQ Global market, under the ticker symbol OXFD.

The company, which is developing tests for infectious and immunological diseases, filed a registration statement Nov. 21 with the U.S. Securities and Exchanges Commission.

Oxford raised some $110 million through five rounds of equity financing between 2002 and mid-2012, with much of the proceeds going toward expanding sales and marketing for a tuberculosis diagnostic test.

Read more

UK Firm Expands To Marlborough | Awaits FDA approval for new TB test

Marlborough Lab Gets Federal TB Testing Contract

Oxford Immunotec Raises $28M To Expand TB Test Sales

Tech, Biotech Help Pump Up Office Market

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF